ONAWA

Window Program

A Window of Opportunity Trial of Onapristone as Preoperative Treatment for Postmenopausal Women with Hormone Receptor-Positive and HER2-negative Breast Cancer

Phase 0

Status

Follow up

Tumour subtype:

HR+

Scenario

Neoadjuvant

SPONSOR

SOLTI

COLLABORATORS

PRINCIPAL INVESTIGATORS

Meritxell Bellet, MD PhD (Vall d’Hebron Institut d’Oncologia, Barcelona)
Cristina Saura, MD PhD (Vall d’Hebron Institut d’Oncologia, Barcelona)

Sites

HOSPITAL CLINIC DE BARCELONA, HOSPITAL UNIVERSITARI ARNAU DE VILANOVA DE LLEIDA, HOSPITAL UNIVERSITARI SANT JOAN DE REUS, HOSPITAL UNIVERSITARI VALL D’HEBRON